Edition:
United Kingdom

IRIDEX Corp (IRIX.OQ)

IRIX.OQ on NASDAQ Stock Exchange Global Market

7.43USD
23 Jan 2018
Change (% chg)

$-0.06 (-0.80%)
Prev Close
$7.49
Open
$7.54
Day's High
$7.59
Day's Low
$7.40
Volume
2,552
Avg. Vol
6,779
52-wk High
$16.09
52-wk Low
$7.40

Chart for

About

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumenta... (more)

Overall

Beta: 1.33
Market Cap(Mil.): $114.98
Shares Outstanding(Mil.): 11.57
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 149.38 16.62
EPS (TTM): -- -- --
ROI: -- 9.44 10.61
ROE: -- 14.87 14.21

BRIEF-Blueline Capital Partners LP Reports 8.5 pct Passive Stake In Iridex Corp As Of Dec. 31, 2017

* BLUELINE CAPITAL PARTNERS LP REPORTS 8.5 PERCENT PASSIVE STAKE IN IRIDEX CORP AS OF DECEMBER 31, 2017 - SEC FILING‍​ Source text - (http://bit.ly/2F0uMll) Further company coverage:

22 Jan 2018

BRIEF-Iridex Corp ‍Filed Lawsuit Against Quantel Medical S.A

* IRIDEX CORP - ‍FILED LAWSUIT AGAINST QUANTEL MEDICAL S.A., QUANTEL USA, QUANTEL, S.A. IN U.S. DISTRICT COURT FOR NORTHERN DISTRICT OF CALIFORNIA​ Source text for Eikon: Further company coverage:

09 Jan 2018

BRIEF-Iridex Corp reports qtrly loss per share $0.27‍​

* Iridex Corp - ‍Iridex reiterates its previously provided estimate for revenue, and g6 system and g6 probe shipments for full year 2017​

02 Nov 2017

BRIEF-Iridex Q2 revenue falls 16 pct

* Iridex announces 2017 second quarter, six-month financial results

03 Aug 2017

Earnings vs. Estimates